Fulcrum Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic from 2020 to 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Fulcrum Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2020 to 2023.
  • Fulcrum Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 62.2M shares.
  • Fulcrum Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 61.3K shares, a 36.3% increase from 2022.
  • Fulcrum Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 45K shares, a 27.2% increase from 2021.
  • Fulcrum Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 35.4K shares, a 39.5% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 61.3K +16.3K +36.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 45K +9.63K +27.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 35.4K +10K +39.5% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-06-26
2020 25.4K Jan 1, 2020 Dec 31, 2020 10-K/A 2023-06-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.